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Abstract
Background: Dermatofibrosarcoma protuberans is a rare tumor, representing about 0.1% of skin malignant tumors.
It is characterized by local aggressiveness with significant potential for recurrence. Although metastasis is rare, it
does occur. We report a case of a Burkinabe woman with dermatofibrosarcoma protuberans.
Case presentation: A 27-year-old Burkinabe woman consulted our institution for a recurrent scalp nodule that had
been evolving for 13 years. At clinical examination, she was in good condition with a dry cough. An atrophic
scarring alopecic plaque of 15-cm diameter in the right parietal region of the scalp, topped by an erythematous
firm nodule measuring 3 × 2 × 2 cm, was noted, as well as a mobile nodule located in the axillary tail of the right
breast. Cerebral computed tomodensitometry had not objectified the reach of the vault or the brain. A thoracic
scan revealed four intrathoracic tissue masses straight to pleural touch. There were no evolutionary lesions in the
abdominopelvic region. Histopathologic examination of the biopsy of the scalp nodule showed a proliferation of
fibrous background, with fusiform cells carrying a storiform appearance. These cells had dark, elongated nuclei and
showed some mitosis without atypia. The cells expressed CD34 intensely and diffusely. The test results were
negative for PS100 and smooth muscle actin. The breast nodule showed the same profile as the scalp nodule.
Conclusions: We concluded on the diagnosis of scalp dermatofibrosarcoma protuberans with breast metastasis
and probable pleuropulmonary metastasis.
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Background
Dermatofibrosarcoma of Darier and Ferrand, or dermato-
fibrosarcoma protuberans (DP), is a low-grade fibrohistio-
cytic tumor characterized by a high rate of local
recurrence [1]. It is a rare tumor, representing 0.1% of ma-
lignant skin tumors [2]. It usually affects adults between
20 and 50 years of age and is located on the trunk and
proximal limbs [3, 4]. The diagnosis of this tumor is often
delayed because of its various clinical presentations. It is
characterized by local aggressiveness with significant
potential for recurrence; although metastasis is rare, it
does occur.
We report a case of a patient with DP of the scalp di-
agnosed after seven recurrences and six undocumented
surgeries. Its uniqueness lies in the discovery of a breast
nodule in the right axillary tail as well as intrathoracic
masses in a 27-year-old woman.
Case presentation
A 27-year-old Burkinabe woman from the north of
Burkina Faso had consulted for a recurrent scalp nodule
that had been evolving for 13 years. The scalp nodule
had relapsed for the seventh time 6 months ago after six
surgeries. It began as a painless nodule of the scalp that
would have benefited from iterative surgical resections
without histologic analysis.
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The patient presented to our institution complaining
of a dry cough lasting for 1 month. She was afebrile and
in good condition. We noted an atrophic, indurated,
scarring alopecic plaque measuring 15 cm in diameter in
the center of her scalp, topped by a firm erythematous
nodule measuring 3 × 2 × 2 cm in projection of the right
parietal region. The nodular mass was slightly movable
to the deep plane and painless.
Three other nodules were also observed that were more
palpable than visible, each measuring 1 cm in diameter, on
the indurated alopecic plaque (Fig. 1). The patient’s phys-
ical examination revealed a painless mobile nodule located
in the axillary tail of the right breast. The result of the pa-
tient’s respiratory system examination was normal. The re-
sults of the rest of her physical examination were normal.
Cranioencephalic computed tomodensitometry (CT)
was performed, which showed a soft tissue mass in the
exophytic right parietal skin, measuring 30 × 24 × 17
mm, enhanced after iodine contrast agent injection.
There were no signs of damage to the cranial vault or
the brain (Fig. 2).
Thoracic CT revealed four intrathoracic tissue masses
that were straight to pleural contact and a nodule of the
axillary tail of the right breast, measuring 23 × 22 × 18
mm (Fig. 3). The breast and chest nodules had the same
characteristics before and after iodine contrast agent
injection. There were no evolutionary lesions in the
abdominopelvic region. Ultrasound of the breast nod-
ule revealed an oval hypoechoic formation with regular
contours. The result of an abdominopelvic ultrasound
was normal.
A histologic study of the scalp nodule biopsy showed a
proliferation of fibrous background fusiform cells carry-
ing a storiform pattern. These cells had elongated, dark
nuclei and showed some mitosis without atypia (three
mitoses per 10 high-power fields at × 40 magnification).
An immunohistochemical study demonstrated that the
cells expressed CD34 intensely and diffusely, but the
result was negative for PS100 (Fig. 5) and smooth
muscle actin.
Histologic and immunohistochemical study of the
breast nodule revealed the presence of a breast mesen-
chymal tumor (Fig. 4) with the same characteristics as
the scalp nodule, and the result was positive for CD34
(Figs. 5 and 6). The combination of clinical, imaging,
histologic, and immunohistochemical findings led us
to a diagnosis of scalp DP with breast metastasis and
probably pleuropulmonary metastasis. Surgery and
chemotherapy with imatinib are being considered for
our patient. After three rounds of chemotherapy, the
breast and chest nodes partially regressed in size.
Discussion
DP was first described by Darier and Ferrand in 1924 as a
progressive and recurrent dermatofibroma [5]. This tumor
Fig. 1 Tumor nodule in alopecic scarring atrophic plaque of
the scalp
Fig. 2 Coronal reconstruction of cerebral computed tomodensitometric scans showing the right parietal exophytic nodule without
bone involvement
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is characterized by slow evolution with a high propensity
for local relapse. Our patient was experiencing a seventh
recurrence. Its location on the scalp is uncommon. In-
deed, the craniofacial location represents about 10% to
15% of the occurrences [6]. Despite its multiple relapses
and disease duration of 13 years in our patient, we have
not found any signs of local bone or intracranial exten-
sion. This was not the case in a report by Abe et al. [7],
who found that DP recurred 7 years after three surgical
resections of nodules of the scalp, brain invasion, and su-
perior sagittal sinus.
DP metastasis is extremely rare. When it occurs, the
preferred location is the lung [4]. The other secondary
locations described are ganglion, brain, pancreas, liver,
testicle, orbit, muscle, and the abdominopelvic region.
Lymph node and visceral metastasis occurs in 1% and
4% of cases, respectively [8]. Chryssogonidis et al. [9]
described pulmonary, brain, and testicular locations;
Mahajan et al. [10] reported brain, muscular, and pleural
locations; Yokoyama et al. [11] reported pancreatic and
muscular locations; Gupta et al. [12] described liver and
cerebral locations; Nakra et al. [13] reported an orbital
location; and Berbis et al. [14] described lung, abdom-
inal, and pelvic locations. A breast secondary location, as
in the case of our patient, is extremely rarely reported in
the literature. Pleuro-pulmonary nodules were probably
metastatic even if they have not been proven
histologically.
Because of the secondary locations of DP, sarcomatous
transformation must be discussed. Indeed, regional and
general metastases are also disclosed in the context of
sarcomatous processing. This sarcomatous transform-
ation can occur in 10% to 20% of DP cases. Histologic
and immunohistochemical criteria of sarcomatous
changes are cellular atypia, a fascicular pattern, ten mi-
toses per 10 high-power fields at × 40 magnification, de-
creased expression of CD34, and increased MIB-1 (EB1)
with more than 5% of tumor tissue transformed. None of
these histologic or immunohistochemical signs for sar-
comatous transformation were found in our patient.
Fig. 3 Coronal reconstruction of thoracic computed tomodensitometric scans showing the right breast nodule (white arrow) and thoracic
extension pleural nodules (red arrows) in touch
Fig. 4 Histologic specimen of the breast nodule showing a storiform
architecture. There is no atypia and no mitosis
Fig. 5 Histologic specimen of the breast nodule showing intense
attachment of CD34
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The differential diagnosis can also include neuro-
fibroma. Immunohistochemical techniques help in the
differential diagnosis. DP tumor cells express CD34
but not PS100 and factor VIIIa, in contrast to diffuse
neurofibroma, which expresses PS100. This typical as-
pect of DP was noted in scalp and breast nodule
samples from our patient. Our patient had DP of the
scalp with breast metastasis and probable pleuropul-
monary metastasis.
The management of DP is surgery. The recommended
surgery is wide excision, removing the tumor en bloc
with wide safety margins of 3 to 5 cm of healthy tis-
sue. This is the only means of therapy that has dem-
onstrated effectiveness in preventing recurrence. In
another surgical method, the Mohs micrographic
technique, the entire tumor is removed while a max-
imum of healthy tissue is conserved using extempor-
aneous three-dimensional intraoperative pathological
control [15]. This technique could not be applied in
our patient. However, chemotherapy with imatinib is
used for locally advanced and metastatic DP, and it is
associated with a 50% response rate [16]. Some au-
thors recommend radiotherapy to reduce the risk of
local recurrence, especially in cases of tumor recur-
rence, invasion of tumor margins, or in locations lim-
iting large resections. Radiotherapy is not available in
our country, so chemotherapy with imatinib and sur-
gery with a wide excision were considered for our
patient.
In general, the survival rate for DP is 99% at 5 years
when there is no metastasis [17]. The prognosis depends
on the quality of the surgical excision, local recurrence,
and the occurrence of metastasis. For our patient, the
prognosis is reserved because of the multirecurrence of
breast and pleuropulmonary metastasis. The 5-year sur-
vival in these recurrent and metastatic cases is on the
order of 12% [17].
Conclusions
DP is a rare tumor characterized by a local malignant
potential. Recurrence is common. The occurrence of
secondary locations is very rare. A breast metastasis is
also extremely uncommon; hence, the interest of our ob-
servations related to breast and pleuropulmonary metas-
tases from scalp DP in a young woman of Burkina Faso.
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Fig. 6 Immunohistochemical examination of the breast nodule. There is no attachment of cytokeratin (a), PS100 (b), or smooth muscle actin (c)
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